Dexbenzetimide in neuroleptic-induced parkinsonism. A double-blind crossover study with a 16-week follow-up.
D000328:Adult; D001774:Blood Chemical Analysis; D002986:Clinical Trials as Topic; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*
D010276:Parasympatholytics; D010919:Placebos; D011725:Pyridines